- Home
- ASO vs VCYT Comparison
ASO vs VCYT Comparison
Compare ASO & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASO | VCYT |
|---|---|---|
| Founded | 1938 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ASO | VCYT |
|---|---|---|
| Price | $54.91 | $42.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $59.06 | $45.38 |
| AVG Volume (30 Days) | ★ 1.9M | 1.0M |
| Earning Date | 12-09-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.48 | 0.38 |
| Revenue | ★ $6,011,862,000.00 | $495,141,000.00 |
| Revenue This Year | $4.05 | $16.02 |
| Revenue Next Year | $6.32 | $10.74 |
| P/E Ratio | ★ $10.13 | $112.61 |
| Revenue Growth | N/A | ★ 16.41 |
| 52 Week Low | $33.34 | $22.61 |
| 52 Week High | $61.25 | $50.71 |
Technical Indicators
Market Signals| Indicator | ASO | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 66.49 | 50.52 |
| Support Level | $48.27 | $45.68 |
| Resistance Level | $50.78 | $45.17 |
| Average True Range (ATR) | 2.33 | 1.95 |
| MACD | 1.09 | -0.70 |
| Stochastic Oscillator | 85.65 | 16.81 |
Price Performance
Historical ComparisonAbout ASO Academy Sports and Outdoors Inc.
Academy Sports and Outdoors Inc is engaged in the full-line sporting goods and outdoor recreation retailer in the United States. The company's product categories are outdoors, apparel, sports & recreation, and footwear.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.